Hotline:
+ 49 (0) 2204 2918806

Market studies for category Regulation & Policy

Items 1 to 10 of 1880 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 188
  1. Net price*
    Year
  2. $300.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Sinovac Biotech Ltd. (SVA) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 Pages
    This comprehensive SWOT profile of Sinovac Biotech Ltd. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile
    Englisch | Zukunftsanalyse | SKU: 86762
  3. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Geneva Bioinformatics SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    18 pages
    Geneva Bioinformatics SA (GeneBio) is a bioinformatics company. The company provides life sciences community with software that bridges the gap between information gathering and knowledge generation. Its products include smileMS, melanie, phenyx, nextport, protein DBs and megaclust. GeneBio’s smileMS is versatile software used for the i
    Englisch | Zukunftsanalyse | SKU: 387836
  4. $300.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    NeoStem, Inc. (NBS) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 Pages
    This comprehensive SWOT profile of NeoStem, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps
    Englisch | Zukunftsanalyse | SKU: 85091
  5. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    NephroGenex, Inc. (NRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    17 pages
    NephroGenex, Inc. (NephroGenex) is a drug-development company. The company develops novel therapies for kidney disease. It develops pyridorin, a therapeutic with pyridoxamine dihydrochloride as its active ingredient in phase II clinical development for the treatment of diabetic kidney disease. NephroGenex will launch the Pyridorin Phase 3
    Englisch | Zukunftsanalyse | SKU: 331754
  6. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Acadia Healthcare, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    19 Pages
    Acadia Healthcare (Acadia) provides healthcare services. The company develops and operates a network of behavioral health centers in the US. It provides psychiatric and chemical dependency services to its patients. Healthcare facilities of Acadia include residential treatment centers, inpatient psychiatric facilities (IPFs), outpatient cl
    Englisch | Zukunftsanalyse | SKU: 270572
  7. $300.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Lee's Pharmaceutical Holdings Limited (950) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 Pages
    This comprehensive SWOT profile of Lee's Pharmaceutical Holdings Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and thr
    Englisch | Zukunftsanalyse | SKU: 86899
  8. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Cantargia AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    18 pages
    Cantargia AB (Cantargia) is a research and development company. The company develops antibodies for treatment of haematological diseases. It develops therapies for the treatment of hematological malignancies, which uses the expression of a unique cell surface receptor on hematopoietic stem cells. Cantargia is developing antibody therapeut
    Englisch | Zukunftsanalyse | SKU: 987672914
  9. $300.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    TTY Biopharm Company Limited (4105) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 pages
    TTY Biopharm Company Limited (TTY) is a biopharmaceutical company. It undertakes research, development and marketing of drugs for cancer, anti-infection and blood vessel diseases. The company’s oncology product portfolio includes TS-1, UFUR, Irino, Gemmis, Epicin, Oxalip, Asadin, Thado, Tyxan, Anazo, Folina and others; and anti-infectio
    Englisch | Zukunftsanalyse | SKU: 150451
  10. $300.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Kainos Laboratories, Inc. (4556) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 Pages
    This comprehensive SWOT profile of KAINOS Laboratories, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The pr
    Englisch | Zukunftsanalyse | SKU: 85222
  11. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    28 pages
    Nektar Therapeutics (Nektar) is a biopharmaceutical company. It carries out discovery and development of a pipeline of novel therapeutic drug candidates based on its PEGylation and advanced polymer conjugate technology platforms to address unmet medical needs. The product pipeline of the company focuses on various therapeutic areas, inclu
    Englisch | Zukunftsanalyse | SKU: 339491

Items 1 to 10 of 1880 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 188